Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome.
Authors
Kulke, MHörsch, D
Caplin, M
Anthony, L
Bergsland, E
Oberg, K
Welin, S
Warner, R
Bohas, C
Kunz, P
Grande, E
Valle, Juan W
Lapuerta, P
Banks, P
Jackson, S
Jiang, W
Biran, T
Pavel, M
Affiliation
Medical Oncology, Dana-Farber Cancer Institute, BostonIssue Date
2016-10-01
Metadata
Show full item recordCitation
Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome. 2016, 27(suppl_6):422PD Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw369.07Additional Links
https://academic.oup.com/annonc/article/2799161/IntegratedType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw369.07